Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.

@article{Kawatani2001IncidenceOH,
  title={Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.},
  author={Toshio Kawatani and Takeaki Suou and Fumihito Tajima and Kiyomi Ishiga and Hiromi Omura and Ayako Endo and Hiroshi Ohmura and Yasushi Ikuta and Youko Idobe and Hirohide Kawasaki},
  journal={European journal of haematology},
  year={2001},
  volume={67 1},
  pages={45-50}
}
Hepatitis virus infection through virus reactivation has a high risk of mortality in patients with hematological malignancies receiving chemotherapy. We examined the incidence of both hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and severe liver dysfunction (alanine aminotransferase >ten times the normal upper limit and total bilirubin >5 mg/dl) during chemotherapy in 268 patients with hematological malignancies. Eight patients (3.0%) were infected with HBV and 22 patients (8.2… CONTINUE READING